# Schedules of Controlled Substances; Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine Into Schedule I of the Controlled Substances Act; Correction
> **Rule** · Final rule: correction. · Published 2010-08-06 · 75 FR 47451
## Document
- **Document number:** 2010-19348
- **Category:** scheduling
- **Type:** Rule
- **Action:** Final rule: correction.
- **Citation:** 75 FR 47451
- **Publication date:** 2010-08-06
## Abstract

The Drug Enforcement Administration (DEA) is correcting a final rule that appeared in the Federal Register of March 18, 2004. The final rule pertained to the scheduling of N-Benzylpiperazine (BZP), and contained an error regarding the potency of BZP relative to amphetamine. Although DEA used the correct figures in arriving at its scheduling determination, the agency is publishing this correction to provide an official statement of the actual figures. This correction does not address the scheduling of 2,5-dimethoxy-4-(n)- propylthiophenethylamine (2C-T-7) which was also placed into schedule I as a result of the above cited rulemaking.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2010/08/06/2010-19348/schedules-of-controlled-substances-placement-of-25-dimethoxy-4-n-propylthiophenethylamine-and)
---
*AI Analytics · CC0 1.0*